ZyVersa Therapeutics Inc (ZVSA)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Nov 15, 16:00
1.06
-0.02
(-1.85%)
After-Hours: 20:00
ZyVersa Therapeutics Total Assets (Quarterly): 19.47M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 19.47M |
| March 31, 2024 | 21.65M |
| December 31, 2023 | 22.11M |
| September 30, 2023 | 32.85M |
| June 30, 2023 | 31.99M |
| Date | Value |
|---|---|
| March 31, 2023 | 114.95M |
| December 31, 2022 | 118.51M |
| September 30, 2022 | 2.346M |
| June 30, 2022 | 1.936M |
| December 31, 2021 | 1.126M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.126M
Minimum
Dec 2021
118.51M
Maximum
Dec 2022
36.69M
Average
21.88M
Median
Total Assets (Quarterly) Benchmarks
| NeuroBo Pharmaceuticals Inc | 22.15M |
| Dermata Therapeutics Inc | 5.237M |
| Cognition Therapeutics Inc | 34.37M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.85M |
| Shareholders Equity (Quarterly) | 8.620M |